Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | XENE Xenon Pharmaceuticals Inc. - Common | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $39.75 -30.7% | $15.06 -2.0% |
| StockIQ Score | 29F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 10F | 13F |
| Fundamental | 30F | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 38F | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Xenon Pharmaceuticals (XENE) scores slightly higher in technical (10 vs. 13) and fundamental (30 vs. 35) metrics, though both are weak. Ascentage Pharma (AAPG) outperforms in growth (50 vs. 32) and ties in valuation (38 vs. 38). AAPG’s growth score is notably stronger, while XENE’s technical edge is minimal.
